The OPT-MVAC consortium’s workplan consists of five distinct work packages (WPs), each tasked with objectives and deliverables pertaining to the project and its execution.
WP1 will ensure the project’s objectives, milestones and deliverables are achieved and the workplan is implemented in compliance with the Grant Agreement and the Consortium Agreement. Responsibilities include project support for financial management, logistics, internal communications and coordination, in compliance with European Commission rules and procedures.
In collaboration with the Université of Thies, LSHTM and WHO-TDR – the Special Programme for Research and Training in Tropical Diseases, WP2 will provide technical support and training to help countries implement research protocols designed to monitor malaria vaccine introduction and identify barriers to uptake and develop mitigation strategies to address potential risks. WP2 will define project priorities and ensure compliance with good clinical practices and international standards.
WP3 will support reliable and timely data generation to drive improvements in immunisation performance. Activities will include harmonising monitoring and evaluation methods across countries to ensure data are comparable and supporting the ethical conduct of data collection, data integrity and data quality. Support to each country will be provided in-person and via email and WhatsApp, led by partners from LSHTM, with support from LIH, WHO-TDR, UIDT and experts in each country.
In collaboration with all consortium partners, WP4 will ensure the selection of administered vaccines in participating countries is based on a positive balance between benefits and risks; that pharmacovigilance systems have the capacity to collect and analyse data to proactively address risks; and that necessary resources are allocated to support the smooth pharmacovigilance operations.
WP5 will share information about the project, its progress and its findings with key stakeholders and engage in activities to facilitate improved access, coverage and trust in vaccines against all preventable infectious diseases
